Structures by: Desper J.
Total: 512
SF3 (4-pyridyl)-CONH-(CH2)6-NHCO-(4-pyridyl), HOOC-(CH2)8-COOH
(C18H22N4O2)(C10H18O4)
Journal of the American Chemical Society (2009) 131, 17048-17049
a=5.1506(4)Å b=5.2481(4)Å c=24.5206(16)Å
α=89.647(4)° β=87.252(4)° γ=88.505(5)°
SF5 (4-pyridyl)-CONH-(CH2)6-NHCO-(4-pyridyl), HOOC-(CH2)10-COOH
(C18H22N4O2)(C12H22O4)
Journal of the American Chemical Society (2009) 131, 17048-17049
a=5.1519(4)Å b=5.2778(5)Å c=26.148(3)Å
α=86.023(6)° β=89.386(6)° γ=88.496(6)°
(E)-2-Butenoic acid 4-amino-4-oxo ethyl ester
C6H9NO3
Journal of the American Chemical Society (2002) 124, 11315-11323
a=20.880(5)Å b=3.9280(10)Å c=8.610(2)Å
α=90.00° β=90.00° γ=90.00°
N-(phenylacetyl)glycine ethyl ester
C12H15NO3
Journal of the American Chemical Society (2002) 124, 11315-11323
a=9.9748(18)Å b=12.130(2)Å c=9.5533(16)Å
α=90.00° β=90.00° γ=90.00°
N-cinnamoyl alanine amide
C14H18N2O2
Journal of the American Chemical Society (2002) 124, 11315-11323
a=13.514(6)Å b=4.7974(19)Å c=21.238(10)Å
α=90.00° β=97.137(7)° γ=90.00°
Fumaric acid bis(leucine methyl ester) amide
C18H30N2O6
Journal of the American Chemical Society (2002) 124, 11315-11323
a=14.440(5)Å b=4.852(2)Å c=27.377(11)Å
α=90.00° β=90.00° γ=90.00°
NSoximeI 4-I-F4-PhCH=NOH
C7H2F4INO
Journal of the American Chemical Society (2007) 129, 13772-13773
a=4.38850(10)Å b=6.00010(10)Å c=31.9307(7)Å
α=90.00° β=93.9030(10)° γ=90.00°
MF-24-57 1-methyl-2-(4-pyridyl)benzimidazole, F5-benzaldehyde oxime
(C13H11N3)(C7H2F5NO)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=6.8616(8)Å b=7.6589(8)Å c=34.632(4)Å
α=90.00° β=90.00° γ=90.00°
NSoximeBr 4-Br-F4-PhCH=NOH
C7H2BrF4NO
Journal of the American Chemical Society (2007) 129, 13772-13773
a=4.2896(3)Å b=5.9991(4)Å c=15.3706(10)Å
α=80.976(3)° β=84.419(4)° γ=88.344(3)°
MF-24-58 1-methyl-2-(4-pyridyl)benzimidazole, 4-Br-F4-PhCH=NOH
(C13H11N3)(C7H2F4NOBr)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=6.8554(3)Å b=7.9485(4)Å c=34.9508(15)Å
α=90.00° β=90.00° γ=90.00°
MF-24-57 1-methyl-2-(4-pyridyl)benzimidazole, 4-I-F4-PhCH=NOH
(C13H11N3)(C7H2F4INO)
Journal of the American Chemical Society (2007) 129, 13772-13773
a=7.2257(5)Å b=10.0969(8)Å c=13.7520(11)Å
α=81.535(6)° β=81.846(4)° γ=74.495(4)°
Trans-1,2-diaminocylohexane monoimine
C14H18N2O3
Inorganic Chemistry (2008) 47, 1120-1126
a=6.1675(8)Å b=11.9167(15)Å c=18.033(2)Å
α=90.00° β=90.00° γ=90.00°
AL-608 (AL-4-26 Fe)
C28H34FeN4O6
Inorganic Chemistry (2008) 47, 1120-1126
a=8.8032(4)Å b=12.5533(6)Å c=12.3334(6)Å
α=90.00° β=95.159(2)° γ=90.00°
AL-4-26 / CoI2-R
(C14H17N2O3)2Co
Inorganic Chemistry (2008) 47, 1120-1126
a=8.8100(8)Å b=12.4866(12)Å c=12.3007(12)Å
α=90.00° β=94.572(4)° γ=90.00°
Al-4-26 Cu(OH)2
(C22H20CuN2O6)(CH4O)
Inorganic Chemistry (2008) 47, 1120-1126
a=7.5321(7)Å b=16.0522(14)Å c=17.4225(15)Å
α=90.00° β=92.7830(10)° γ=90.00°
AL-4-26/NiI2-R
(C14H17N2O3)2Ni
Inorganic Chemistry (2008) 47, 1120-1126
a=8.8514(6)Å b=12.5256(9)Å c=12.1886(9)Å
α=90.00° β=94.5630(10)° γ=90.00°
AL-4-26/ZnCl2-R
(C14H17N2O3)2Zn
Inorganic Chemistry (2008) 47, 1120-1126
a=8.7802(7)Å b=12.5067(10)Å c=12.3400(10)Å
α=90.00° β=94.8560(10)° γ=90.00°
(1,3-Ph2acac)Co(II), 4-[(2-MeBenzIm)methyl]PhCONH2 (THF)
Co(C15H11O2)2(C16H15N3O)2(C4H8O)2
Inorganic Chemistry (2009) 48, 4052-4061
a=8.9670(6)Å b=11.2006(7)Å c=15.3238(9)Å
α=75.533(3)° β=80.377(4)° γ=79.221(4)°
(1,3-Ph2acac)Ni(II), 4-[(2-MeBenzIm)methyl]PhCONH2 (THF)2
Ni(C15H11O2)2(C16H15N3O)2(C4H8O)2
Inorganic Chemistry (2009) 48, 4052-4061
a=8.9948(19)Å b=11.185(2)Å c=15.409(3)Å
α=75.737(9)° β=79.844(13)° γ=78.971(16)°
Cu{[4-(5,6-dimethylbenzimidazol-1-yl)methyl]benzamide}2(F6-acac)2 (CH3CN)2
Cu(C17H17N3O)2(C5HO2F6)2(C2H3N)2
Inorganic Chemistry (2009) 48, 4052-4061
a=10.349(3)Å b=10.688(3)Å c=12.680(3)Å
α=98.217(6)° β=110.457(5)° γ=104.465(5)°
{3-[(pyrazol-1-yl)methyl]benzamide}2 (F6-acac)4 Cu(II)2
(C11H11N3O)2(C5H1F6O2)4Cu2
Inorganic Chemistry (2009) 48, 4052-4061
a=9.7354(11)Å b=11.1497(12)Å c=23.870(3)Å
α=90.00° β=96.985(2)° γ=90.00°
Bis{4-[(pyrazol-1-yl)methyl]benzamide} (Ph2-acac)2 Ni(II) bis{ethanol} (Ph2-acac)2 Ni(II)
(C11H11N3O)2(C15H11O2)2Ni(C2H6O)2(C15H11O2)2Ni
Inorganic Chemistry (2009) 48, 4052-4061
a=9.0170(6)Å b=12.3493(8)Å c=17.6357(12)Å
α=86.3190(10)° β=78.0890(10)° γ=72.2410(10)°
{3-[(pyrazol-1-yl)methyl]benzamide}2 (F6-acac)4 Cu(II)2
(C11H11N3O)2(C5H1F6O2)4Cu2
Inorganic Chemistry (2009) 48, 4052-4061
a=10.0325(10)Å b=15.1765(15)Å c=16.6440(16)Å
α=90.00° β=99.957(2)° γ=90.00°
527 4-[(2-phenylimidazol-1-yl)methyl]benzamide, mu-Cu2(F-PhCOO)4
(C17H15N3O)2(C7H4O2F)4Cu2(C2H3N)5
Inorganic Chemistry (2009) 48, 4052-4061
a=10.9536(9)Å b=11.2155(8)Å c=14.9765(12)Å
α=77.570(6)° β=78.159(4)° γ=74.526(5)°
BS-2-11e mu(o-FPhCOO)4 Cu2[4-imidazolylmethylbenzamide]2
(C11H11N3O)2Cu2(C7H4O2F)4
Inorganic Chemistry (2009) 48, 4052-4061
a=10.8218(9)Å b=19.4000(14)Å c=12.0541(8)Å
α=90.00° β=108.346(4)° γ=90.00°
BS-3-44-2A 4-[(pyrazol-1-yl)methyl]PhCONH2, mu4-(AcO)Cu CH3CN
(C11H11N3O)2Cu2(C2H3O2)4(C2H3N)2
Inorganic Chemistry (2009) 48, 4052-4061
a=7.5896(5)Å b=10.0990(7)Å c=13.3959(8)Å
α=68.531(4)° β=82.310(3)° γ=72.114(3)°
Mu(OAc)4 Cu2 {3-[(pyrazol-1-yl)methyl]benzamide}2
(C2H3O2)4Cu2(C11H11N3O1)2
Inorganic Chemistry (2009) 48, 4052-4061
a=8.0173(4)Å b=10.1615(5)Å c=11.4846(6)Å
α=110.1640(10)° β=109.1250(10)° γ=90.5040(10)°
(F6-acac)2[3-(2-amino-4-methoxypyrimidin-6-yl)pyridine]2Cu(II) (CHCl3)2
(C5HF6O2)2(C10H10N4O)2Cu(CHCl3)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.4149(6)Å b=12.1682(7)Å c=18.2488(10)Å
α=105.6980(10)° β=105.8970(10)° γ=93.1160(10)°
Bis(1,3-Ph2propanedionato)-bis[3(2-amino-4-methoxypyrimidin-6-yl) pyridine]Co(II)
(C15H11O2)2(C10H10N4O)2Co
Inorganic Chemistry (2005) 44, 4983-4991
a=9.3368(7)Å b=10.3686(8)Å c=11.0609(8)Å
α=85.536(2)° β=79.677(2)° γ=83.026(2)°
[1-(2-amino-4-Methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne]2, Co(PhCOCCOPh)2
(C13H12N4O)2Co(C15H11O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.5076(5)Å b=10.7568(6)Å c=11.9544(6)Å
α=68.9160(10)° β=82.6200(10)° γ=69.1900(10)°
1-(2-amino-4-Methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, Ni(Ph2acac)2
Ni(C13H12N4O)2(C15H11O2)2
Inorganic Chemistry (2005) 44, 4983-4991
a=10.4666(7)Å b=10.6669(7)Å c=11.9828(8)Å
α=68.678(4)° β=82.626(4)° γ=69.230(3)°
4-[(2-methylbenzimidazol-1-yl)methyl]benzamide
C16H15N3O
Crystal Growth & Design (2005) 5, 3 1283
a=9.9852(13)Å b=15.912(2)Å c=8.3680(13)Å
α=90.00° β=93.480(9)° γ=90.00°
4-[(2-chlorobenzimidazol-1-yl)methyl]benzamide
(C15H12ClN3O)(H2O)
Crystal Growth & Design (2005) 5, 3 1283
a=6.0212(10)Å b=12.4652(19)Å c=19.166(3)Å
α=90.00° β=90.00° γ=90.00°
(4-bromo-phenylacetonitrile oxime)2, 1,4-di[(1-benzimidazolyl)methyl]benzene
(C8H5BrN2O)2(C22H18N4)
Crystal Growth & Design (2006) 6, 4 1033
a=11.436(4)Å b=5.640(2)Å c=26.449(9)Å
α=90.00° β=99.252(5)° γ=90.00°
(4-bromo-phenylacetonitrile oxime)2, 1,4-di[(1-imidazolyl)methyl]benzene
(C8H5BrN2O)2(C14H14N4)
Crystal Growth & Design (2006) 6, 4 1033
a=12.9436(5)Å b=5.1863(2)Å c=21.6419(9)Å
α=90.00° β=93.4500(10)° γ=90.00°
(4-bromo-PhC(CN)(=NOH))2, 1,4-di[(2-methyl-1-imidazolyl)methyl]benzene
(C8H5BrN2O)2(C16H18N4)
Crystal Growth & Design (2006) 6, 4 1033
a=7.0034(8)Å b=10.6013(12)Å c=11.1605(12)Å
α=77.000(2)° β=75.995(2)° γ=84.920(2)°
(3-chloro-phenylacetonitrile oxime)2, 1,4-di[(1-imidazolyl)methyl]benzene
(C8H5ClN2O)2(C14H14N4)
Crystal Growth & Design (2006) 6, 4 1033
a=5.9000(10)Å b=7.2231(12)Å c=17.088(3)Å
α=86.114(3)° β=89.633(4)° γ=73.472(3)°
1,4-[bis(2-methylbenzimidazol-1-yl)methyl]benzene, (4-bromobenzacetoxime)2
(C24H22N4)(C8H8NOBr)2
Crystal Growth & Design (2006) 6, 4 1033
a=10.9286(11)Å b=14.1612(15)Å c=11.3704(12)Å
α=90.00° β=92.619(2)° γ=90.00°
3-[(benzimidazol-1-yl)methyl]benzamide
C15H13N3O
Crystal Growth & Design (2005) 5, 3 1283
a=9.2133(11)Å b=11.6848(13)Å c=12.1071(15)Å
α=104.058(9)° β=98.623(8)° γ=94.900(7)°
3-[(2-chlorobenzimidazol-1-yl)methyl]-benzamide
C15H12ClN3O
Crystal Growth & Design (2005) 5, 3 1283
a=8.8067(7)Å b=11.8803(12)Å c=14.0856(15)Å
α=74.800(4)° β=72.485(5)° γ=68.786(4)°
3-[(benzimidazol-1-yl)methyl]benzamide, 4-nitrobenzoic acid
(C15H13N3O)(C7H5NO4)
Crystal Growth & Design (2005) 5, 3 1283
a=7.5178(9)Å b=9.1850(11)Å c=15.0850(15)Å
α=105.516(6)° β=100.600(7)° γ=100.339(8)°
3-[(2-methylbenzimidazol-1-yl)methyl]PhCOOH,(4-NO2PhCOOH)2
(C16H15N3O)(C7H5NO4)2
Crystal Growth & Design (2005) 5, 3 1283
a=7.5292(5)Å b=11.0980(8)Å c=17.2512(11)Å
α=81.865(4)° β=77.854(3)° γ=74.581(4)°
[N-(2-pyridyl)acetamide]2, pentanedioic acid
(C7H8N2O)2(C5H8O4)
Crystal Growth & Design (2006) 6, 2 474
a=7.2671(11)Å b=34.592(5)Å c=8.6020(12)Å
α=90.00° β=114.553(2)° γ=90.00°
[N-(2-pyridyl)acetamide]2, heptanedioic acid
(C7H8N2O)2(C7H12O4)
Crystal Growth & Design (2006) 6, 2 474
a=14.3348(6)Å b=16.1008(7)Å c=18.8047(12)Å
α=90.00° β=90.0020(10)° γ=90.00°
[N-(2-pyridyl)acetamide]2, octanedioic acid
(C7H8N2O)2(C8H14O4)
Crystal Growth & Design (2006) 6, 2 474
a=13.566(2)Å b=9.2129(15)Å c=17.641(3)Å
α=90.00° β=101.162(2)° γ=90.00°
[N-(2-pyridyl) acetamide]2, fumaric acid
(C7H8N2O)2(C4H4O4)
Crystal Growth & Design (2006) 6, 2 474
a=4.8875(5)Å b=8.4817(8)Å c=11.4723(11)Å
α=110.375(2)° β=91.000(2)° γ=96.451(2)°
[N-(2-pyridyl)acetamide]2, succinic acid
(C7H8N2O)2(C4H6O4)
Crystal Growth & Design (2006) 6, 2 474
a=9.1172(8)Å b=9.2969(8)Å c=10.6430(9)Å
α=90.00° β=92.694(2)° γ=90.00°
[N-(2-pyridyl)acetamide]2, nonanedioic acid
(C7H8N2O)2(C9H16O4)
Crystal Growth & Design (2006) 6, 2 474
a=16.563(3)Å b=8.5279(12)Å c=18.464(3)Å
α=90.00° β=114.909(9)° γ=90.00°
[N-(2-pyridyl)acetamide]2, decanedioic acid
(C7H8N2O)2(C10H18O4)
Crystal Growth & Design (2006) 6, 2 474
a=5.3767(4)Å b=6.5416(4)Å c=17.0662(12)Å
α=92.8090(10)° β=90.2470(10)° γ=101.3140(10)°
N-(3-pyridyl)acetamide, 5-nitroisophthalic acid
(C7H8N2O)2(C8H5NO6)
Crystal Growth & Design (2006) 6, 2 474
a=19.5362(14)Å b=9.3631(7)Å c=12.7665(10)Å
α=90.00° β=113.382(4)° γ=90.00°
2-amino-4-methyl-6-(3-pyridyl)pyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=6.9426(4)Å b=7.2048(5)Å c=9.3201(6)Å
α=92.459(4)° β=91.380(4)° γ=107.319(4)°
2-amino-4-(4-pyridyl)-6-methylpyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=5.5629(4)Å b=7.4679(6)Å c=22.1080(18)Å
α=90.00° β=90.00° γ=90.00°
2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine
C11H12N4O
Crystal Growth & Design (2007) 7, 11 2324
a=11.6368(8)Å b=7.2494(5)Å c=24.7339(17)Å
α=90.00° β=90.00° γ=90.00°
1-(2-aminopyrimidin-5-yl)-2-(pyrid-3-yl)ethyne
C12H9N3
Crystal Growth & Design (2007) 7, 11 2324
a=8.6286(6)Å b=15.3249(10)Å c=8.1780(6)Å
α=90.00° β=115.5070(10)° γ=90.00°
1-(6-amino-3-pyridyl)-2-(4-{benzimidazol-1-yl}phenyl) ethyne
C21H16N4
Crystal Growth & Design (2007) 7, 11 2324
a=5.132(2)Å b=10.542(4)Å c=15.457(6)Å
α=83.343(19)° β=89.94(3)° γ=88.14(3)°
NS10b 2-amino-4-(4-pyridyl)-6-methylpyrimidine
C10H10N4
Crystal Growth & Design (2007) 7, 11 2324
a=12.7944(9)Å b=12.9712(9)Å c=23.1035(15)Å
α=90.00° β=90.246(4)° γ=90.00°
1-(2-amino-4-methylpyrimidin-6-yl)-2-(3-methoxypyridin-5-yl)ethyne, (CH2Cl2)0.5
(C13H12N4O)(C1H2CL2)0.5
Crystal Growth & Design (2007) 7, 11 2324
a=7.2432(8)Å b=7.7893(8)Å c=12.6950(13)Å
α=107.292(2)° β=91.059(2)° γ=98.566(2)°
PC-4-55-5 (4-Br-F4-phenyl)-4-I-F4-benzamide, 1,2-bis(4-pyridyl)ethane
(C13HBrF8INO)(C12H12N2)
Crystal Growth & Design (2013) 13, 9 4145
a=15.2758(8)Å b=7.9588(4)Å c=20.3245(10)Å
α=90.00° β=99.899(2)° γ=90.00°
PC-4-55-8 (4-Br-F4-phenyl)-4-I-F4-benzamide, 1,2-bis(4-pyridyl)ethylene
(C13HBrF8IN)(C12H10N2O)
Crystal Growth & Design (2013) 13, 9 4145
a=4.6568(3)Å b=11.0639(6)Å c=12.2258(7)Å
α=98.373(2)° β=100.443(2)° γ=97.995(2)°
PC-4-55-6 (4-Br-F4-phenyl)-4-I-F4-benzamide, 4,4-bipyridyl
(C13HBrF8INO)2(C10H8N2)
Crystal Growth & Design (2013) 13, 9 4145
a=4.7774(7)Å b=7.9111(10)Å c=25.928(4)Å
α=89.199(8)° β=85.294(9)° γ=75.073(8)°
PC-4-10e (2-aminopyrazine)2, 1,4-diiodotetrafluorobenzene
(C4H5N3)2(C6I2F4)
Crystal Growth & Design (2011) 11, 12 5333
a=7.9013(6)Å b=5.6116(4)Å c=20.1258(16)Å
α=90.00° β=101.260(4)° γ=90.00°
4-11e 2-amino-5-bromopyrazine, 1,4-diiodotetrafluorobenzene
(C4H4N3Br)2(C6F4I2)
Crystal Growth & Design (2011) 11, 12 5333
a=5.6316(6)Å b=8.1219(9)Å c=21.226(2)Å
α=90.00° β=93.035(4)° γ=90.00°
4-12e (3-amino-2,6-dibromopyrazine)2, 1,4-diiodotetrafluorobenzene
(C4H3N3Br2)2(C6F4I2)
Crystal Growth & Design (2011) 11, 12 5333
a=5.6428(4)Å b=9.7705(7)Å c=10.4014(7)Å
α=100.821(3)° β=103.743(3)° γ=93.752(3)°
SVP-4N-GA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)3-COOH
(C11H9N3O)(C5H8O4)
Crystal Growth & Design (2012) 12, 5 2579
a=5.1663(6)Å b=9.9211(10)Å c=15.8829(17)Å
α=75.339(3)° β=82.551(3)° γ=78.820(3)°
SVP-4N-PA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)5-COOH
(C11H9N3O)(C7H12O4)
Crystal Growth & Design (2012) 12, 5 2579
a=7.5855(12)Å b=21.675(3)Å c=11.1031(16)Å
α=90.00° β=96.050(9)° γ=90.00°
SVP 4N-SeA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)6-COOH
(C11H9N3O)(C8H14O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.4438(7)Å b=10.1874(5)Å c=16.5671(9)Å
α=90.00° β=95.023(3)° γ=90.00°
SVP-4N-SeA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)8-COOH
(C11H9N3O)(C10H18O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.0319(11)Å b=9.9500(9)Å c=18.7354(18)Å
α=90.00° β=90.323(4)° γ=90.00°
SVP-4n-AzA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)7-COOH
(C11H9N3O)(C9H16O4)
Crystal Growth & Design (2012) 12, 5 2579
a=5.6707(3)Å b=10.8221(6)Å c=17.0848(10)Å
α=104.161(2)° β=94.599(2)° γ=104.840(2)°
SVP-3N-AA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)4-COOH
(C11H9N3O)(C6H10O4)
Crystal Growth & Design (2012) 12, 5 2579
a=8.9361(8)Å b=9.8031(9)Å c=9.8270(9)Å
α=83.130(2)° β=74.507(3)° γ=79.462(2)°
SVP-3N-SA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)2-COOH
(C11H9N3O)(C4H6O4)
Crystal Growth & Design (2012) 12, 5 2579
a=4.8289(5)Å b=11.1223(11)Å c=14.3787(14)Å
α=67.856(4)° β=89.550(4)° γ=87.878(4)°
SVP-3N-SeA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)8-COOH
(C11H9N3O)(C10H18O4)
Crystal Growth & Design (2012) 12, 5 2579
a=7.5703(8)Å b=9.6882(10)Å c=13.9977(14)Å
α=85.455(4)° β=81.210(4)° γ=79.358(4)°
SVP-3N-MA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)-COOH
(C11H9N3O)(C3H4O4)
Crystal Growth & Design (2012) 12, 5 2579
a=31.2168(18)Å b=4.7940(3)Å c=22.7743(13)Å
α=90.00° β=128.375(2)° γ=90.00°
(2) 3N/AZA BD (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)7-COOH
(C11H9N3O)(C9H16O4)
Crystal Growth & Design (2012) 12, 5 2579
a=13.5588(13)Å b=9.4660(10)Å c=15.8384(15)Å
α=90.00° β=105.946(4)° γ=90.00°
SVP-4N-AA (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)4-COOH
(C11H9N3O)(C6H10O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.9508(11)Å b=19.8752(19)Å c=7.3996(8)Å
α=90.00° β=105.384(4)° γ=90.00°
SVP-4N-SUC (4-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)2-COOH
(C11H9N3O)(C4H6O4)
Crystal Growth & Design (2012) 12, 5 2579
a=11.2578(7)Å b=19.6623(11)Å c=19.8130(12)Å
α=93.236(3)° β=91.236(3)° γ=90.298(3)°
SVP-3N-PA (3-pyridyl)-CONH-(2-pyridyl), HOOC-(CH2)5-COOH
(C11H9N3O)(C7H12O4)
Crystal Growth & Design (2012) 12, 5 2579
a=7.5711(5)Å b=11.9820(8)Å c=20.1758(13)Å
α=82.560(4)° β=80.081(4)° γ=85.195(4)°
EH-4-97-4 4-Br-pyrazole, 3,5-(NO2)2-PhCOOH
(C3H3N2Br)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=7.6597(9)Å b=13.4779(16)Å c=13.7575(16)Å
α=117.048(4)° β=90.413(5)° γ=90.972(4)°
EH-1-25-05 4-CN-PhCOOH, 4-I-pyrazole
(C8H5NO2)(C3H3N2I)
Crystal Growth & Design (2012) 12, 11 5806
a=6.7767(5)Å b=8.0047(6)Å c=11.1806(10)Å
α=83.315(4)° β=77.745(4)° γ=85.862(4)°
EH-01-25-06 3,5-(NO2)2-PhCOOH, 4-I-pyrazole
(C7H4N2O6)(C3H3N2I)
Crystal Growth & Design (2012) 12, 11 5806
a=10.1937(6)Å b=11.2088(6)Å c=13.1357(7)Å
α=111.112(2)° β=108.116(2)° γ=92.381(2)°
EH-6-65-12 3,5-Me2-4-Cl-pyrazole, 3-MeO-4-HO-PhCOOH
(C5H7N2Cl)(C8H8O4)
Crystal Growth & Design (2012) 12, 11 5806
a=12.8138(7)Å b=7.2047(4)Å c=15.2522(9)Å
α=90.00° β=90.00° γ=90.00°
EH-6-65-11 3,5-Me2-4-Cl-pyrazole, 3,5-(NO2)2-PhCOOH
(C5H7N2Cl)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=6.4021(4)Å b=7.8731(5)Å c=28.0067(19)Å
α=90.00° β=90.195(3)° γ=90.00°
EH-4-45-3 3,5-Me2-4-Br-pyrazole, 3,5-(NO2)2-PhCOOH
(C5H7N2Br)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=6.4192(7)Å b=8.0239(8)Å c=28.206(3)Å
α=90.00° β=90.00° γ=90.00°
EH-6-65-6 (3,5-Me2-4-Cl-pyrazole)2, 2,4-(NO2)2-PhCOOH
(C5H7N2Cl)2(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=9.3369(18)Å b=10.489(2)Å c=11.923(2)Å
α=77.852(12)° β=75.218(11)° γ=68.606(12)°
EH-6-65-23 3,5-Me2-4-I-pyrazole, 3,5-(NO2)2-PhCOOH
(C5H7N2I)(C7H4N2O6)
Crystal Growth & Design (2012) 12, 11 5806
a=7.1993(5)Å b=7.8251(6)Å c=13.4055(10)Å
α=93.999(3)° β=90.564(3)° γ=96.990(3)°
EH-4-90-1 pyrazole, 3,5-Cl2-PhCOOH
(C3H4N2)(C7H4O2Cl2)2
Crystal Growth & Design (2012) 12, 11 5806
a=7.7111(12)Å b=9.6247(14)Å c=14.275(2)Å
α=73.355(8)° β=89.353(9)° γ=68.778(7)°
EH-3-94-1 3,5-Me2-pyrazole, 3,5-dinitrobenzoic acid hydrate
(C5H8N2)(C7H4N2O6)(H2O)
Crystal Growth & Design (2012) 12, 11 5806
a=8.6114(4)Å b=6.2504(3)Å c=27.4741(13)Å
α=90.00° β=94.822(3)° γ=90.00°
EH-3-93-7 pyrazole, [(NO2)2-PhCOOH]2
(C3H4N2)(C7H4N2O6)2
Crystal Growth & Design (2012) 12, 11 5806
a=7.1717(6)Å b=13.2773(12)Å c=20.7542(16)Å
α=90.00° β=92.463(4)° γ=90.00°
PC-4-43-6 1-bromo-4-iodotetrafluorobenzene, (2,3,5,6-tetramethylpyrazine)2
(C6BrF4I)(C8H12N2)2
Crystal Growth & Design (2013) 13, 9 4145
a=7.0820(4)Å b=9.4394(5)Å c=9.9426(6)Å
α=70.354(2)° β=69.519(2)° γ=83.639(2)°
PC-4-45-6 1-I-4-(4-Br-F4-phenyl)-F4-benzene, 2,3,5,6-Me4-pyridine
(C12BrF8I)(C8H12N2)
Crystal Growth & Design (2013) 13, 9 4145
a=13.6678(7)Å b=13.8355(8)Å c=11.3735(6)Å
α=90.00° β=104.064(2)° γ=90.00°
PC-3-86a N-(4-I-phenyl)-4-Br-F4-benzamide
C13H5BrF4INO
Crystal Growth & Design (2013) 13, 9 4145
a=7.1847(7)Å b=25.234(3)Å c=8.0401(8)Å
α=90.00° β=107.157(5)° γ=90.00°
PC-4-45-3 1-iodo-4-(4-bromotetrafluorophenyl)-tetrafluorobenzene, 4-(1-pyrrolidinyl)-pyridine
(C12BrF8I)(C9H12N2)
Crystal Growth & Design (2013) 13, 9 4145
a=13.3208(8)Å b=23.8060(14)Å c=7.8323(4)Å
α=90.00° β=123.017(3)° γ=90.00°
PC-4-45-2 1-iodo-4-(4-bromotetrafluorophenyl)-tetrafluorobenzene, 4-(dimethylamino)pyridine
(C12BrF8I)(C7H10N2)
Crystal Growth & Design (2013) 13, 9 4145
a=7.7850(5)Å b=11.3455(7)Å c=12.8117(9)Å
α=114.949(3)° β=95.310(3)° γ=90.597(3)°
2-amino-4-(6-methoxy-3-pyridyl)-6-methylpyrimidine, 4-(Me2N)-PhCOOH
(C11H12N4O)(C9H11NO2)
New Journal of Chemistry (2006) 30, 10 1452
a=7.8442(12)Å b=8.8879(14)Å c=14.216(2)Å
α=101.607(2)° β=90.830(2)° γ=106.753(2)°
P13 2,6-Br2-3-NH2-pyrazine, 2,5-(HO)2-PhCOOH
(C4H3N3Br2)(C7H6O4)
CrystEngComm (2012) 14, 18 5845
a=6.8754(7)Å b=7.1197(7)Å c=13.8665(14)Å
α=87.951(3)° β=86.435(3)° γ=72.915(4)°
2(C6H6N2O),C6F4I2
2(C6H6N2O),C6F4I2
Chemical Communications (Cambridge, United Kingdom) (2007) 41 4236-4238
a=20.247(3)Å b=5.0710(9)Å c=21.279(3)Å
α=90.00° β=106.911(6)° γ=90.00°
KEDPK24 3H-imidazo[4,5-b]pyridine, N-(2-methylphenyl)-N-(2-nitrophenyl)-urea
(C6H5N3)(C14H13N3O3)
Chem.Commun. (2013) 49, 7929
a=11.7996(19)Å b=13.972(2)Å c=14.171(2)Å
α=119.480(10)° β=104.641(11)° γ=93.902(11)°
CVT-53-B2 bromo pentyl ethylene cavitand
(C56H68Br4O8)2(C2H3N1)5
CrystEngComm (2014) 16, 18 3796
a=14.9430(6)Å b=17.0436(7)Å c=26.1853(11)Å
α=101.948(2)° β=97.566(2)° γ=111.014(2)°
DW-3-8 (3-pyridyl)-CONH-(CH2)4-NHCO-(3-pyridyl), I-(CF2)4-I
(C14H14N4O2)(C4F8I2)
CrystEngComm (2014) 16, 44 10203
a=12.7557(6)Å b=9.5667(5)Å c=9.7394(5)Å
α=90.00° β=110.9880(10)° γ=90.00°
AR-1c-aa13 [N-(5-bromo-2-pyridyl)propionamide]2, fumaric acid
(C8H9N2OBr)2(C4H4O4)
CrystEngComm (2010) 12, 12 4231
a=4.8333(3)Å b=9.5923(5)Å c=23.7901(12)Å
α=90.00° β=90.961(2)° γ=90.00°
AR-1i-9 2-amino-3,5-dibromopyridine, 3,5-dinitrobenzoic acid
(C5H4Br2N2)(C7H4N2O6)
CrystEngComm (2010) 12, 12 4231
a=7.3849(5)Å b=31.340(2)Å c=13.3082(9)Å
α=90.00° β=90.344(3)° γ=90.00°